Dorton Katina 4
4 · Prelude Therapeutics Inc · Filed Oct 20, 2025
Insider Transaction Report
Form 4
Dorton Katina
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-10-17+76,000→ 76,000 totalExercise: $1.19Exp: 2035-10-16→ Common Stock (76,000 underlying)
Footnotes (1)
- [F1]The option award vests over a three year period equally one-thirty-sixth per month, subject to Reporting Person's continued service to the Company on each vesting date.